The AACR–Kids Beating Cancer Margaret Guedes Monosomy 7 Legacy Cancer Research Grant 2027 supports innovative research addressing poorly understood and high-risk subtypes of acute myeloid leukemia (AML), particularly monosomy 7 AML. The grant aims to advance understanding of disease biology, therapeutic vulnerabilities, treatment resistance, relapse, and survivorship. AACR
Eligibility Criteria
- Applicants must hold a PhD, MD, MD/PhD, or equivalent doctoral degree.
- Applicants must be independent, non-mentored investigators.
- Applicants must be based at an academic, medical, or research institution anywhere in the world.
- Applicants must be AACR Active Members in good standing by the application deadline.
- Applicants cannot be employees or subcontractors of U.S. federal government entities or for-profit companies.
- Applicants cannot concurrently hold another AACR grant during the grant term. AACR
Funding Details
- Funding: $300,000
- Duration: 3 years
- Grant start: April 1, 2027
Deadline
- Application deadline: December 1, 2026, at 1:00 PM ET
- Decision: February 2027
Further Information
- Projects may investigate disease mechanisms, therapeutic vulnerabilities, biomarkers, MRD, treatment response, relapse, survivorship, and healthcare disparities.
- Applications are submitted through ProposalCentral.
- There are no citizenship or geographic restrictions.
- Official Program Page.